Newborn Genetic Screening

Newborn genetic screening is the practice of testing every newborn for certain harmful or treatable genetic disorders in newborn infants.  Babies with these conditions appear normal at birth. It is only with time that the conditions affects the baby’s brain or physical development or causes other medical problems. By then the damage may be permanent.  Early diagnosis and treatment can result in normal growth and development and can reduce morbidity and mortality.

  • Neonatal Cellular Bioenergetics
  • Neonatal Screenings
  • Phenylketonuria (PKU)
  • Neonatal Pharmacokinetics
  • Neonatal Seizures
  • Genetic Abnormalities

Related Conference of Newborn Genetic Screening

May 23-24, 2024

37th World Pediatrics Conference

Zurich, Switzerland
May 27-28, 2024

36th European Pediatrics Congress

Amsterdam, Netherlands
June 13-14, 2024

32nd World Congress on Clinical Pediatrics

Rome, Italy
June 13-14, 2024

22nd World Congress on Clinical Pediatrics

Rome, Italy
June 13-14, 2024

3rd World Pediatric Conference

Rome, Italy
June 19-20, 2024

9th Annual Summit on Pediatric Cardiology

Rome, Italy
July 17-18, 2024

7th World Pediatric Infectious Disease Congress

Zurich, Switzerland
July 18-19, 2024

35th European Pediatrics Conference

Paris, France
August 19-20, 2024

25th Annual World Congress on Pediatrics

Zurich, Switzerland
September 05-06, 2024

24th World Congress on Pediatric Neurology and Neuropathology

Brussels, Belgium
September 12-13, 2024

28th World Nutrition and Pediatrics Healthcare Conference

Paris, France
September 19-20, 2024

25th World Congress on Pediatric Oncology and Cancer Care

Paris, France
September 19-20, 2024

3rd International Conference on Neonatology

Paris, France
October 21-22, 2024

33rd World Neonatal, Pediatric and Family Medicine Conference

Zurich, Switzerland

Newborn Genetic Screening Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in